Melanoma risk prediction using a multilocus genetic risk score in the Women's Health Initiative cohort

Hyunje G. Cho, Katherine J. Ransohoff, Lingyao Yang, Haley Hedlin, Themistocles Assimes, Jiali Han, Marcia Stefanick, Jean Y. Tang, Kavita Y. Sarin

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: Single-nucleotide polymorphisms (SNPs) associated with melanoma have been identified though genome-wide association studies. However, the combined impact of these SNPs on melanoma development remains unclear, particularly in postmenopausal women who carry a lower melanoma risk. Objective: We examine the contribution of a combined polygenic risk score on melanoma development in postmenopausal women. Methods: Genetic risk scores were calculated using 21 genome-wide association study–significant SNPs. Their combined effect on melanoma development was evaluated in 19,102 postmenopausal white women in the clinical trial and observational study arms of the Women's Health Initiative dataset. Results: Compared to the tertile of weighted genetic risk score with the lowest genetic risk, the women in the tertile with the highest genetic risk were 1.9 times more likely to develop melanoma (95% confidence interval 1.50-2.42). The incremental change in c-index from adding genetic risk scores to age were 0.075 (95% confidence interval 0.041-0.109) for incident melanoma. Limitations: Limitations include a lack of information on nevi count, Fitzpatrick skin type, family history of melanoma, and potential reporting and selection bias in the Women's Health Initiative cohort. Conclusion: Higher genetic risk is associated with increased melanoma prevalence and incidence in postmenopausal women, but current genetic information may have a limited role in risk prediction when phenotypic information is available.

Original languageEnglish (US)
JournalJournal of the American Academy of Dermatology
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Women's Health
Melanoma
Single Nucleotide Polymorphism
Confidence Intervals
Selection Bias
Nevus
Genome-Wide Association Study
Observational Studies
Clinical Trials
Genome
Skin
Incidence

Keywords

  • genetic risk score
  • melanoma
  • postmenopausal
  • single-nucleotide polymorphism
  • women
  • Women's Health Initiative

ASJC Scopus subject areas

  • Dermatology

Cite this

Melanoma risk prediction using a multilocus genetic risk score in the Women's Health Initiative cohort. / Cho, Hyunje G.; Ransohoff, Katherine J.; Yang, Lingyao; Hedlin, Haley; Assimes, Themistocles; Han, Jiali; Stefanick, Marcia; Tang, Jean Y.; Sarin, Kavita Y.

In: Journal of the American Academy of Dermatology, 01.01.2018.

Research output: Contribution to journalArticle

Cho, Hyunje G. ; Ransohoff, Katherine J. ; Yang, Lingyao ; Hedlin, Haley ; Assimes, Themistocles ; Han, Jiali ; Stefanick, Marcia ; Tang, Jean Y. ; Sarin, Kavita Y. / Melanoma risk prediction using a multilocus genetic risk score in the Women's Health Initiative cohort. In: Journal of the American Academy of Dermatology. 2018.
@article{619eaa55753a4e69bcfc2148f252a98e,
title = "Melanoma risk prediction using a multilocus genetic risk score in the Women's Health Initiative cohort",
abstract = "Background: Single-nucleotide polymorphisms (SNPs) associated with melanoma have been identified though genome-wide association studies. However, the combined impact of these SNPs on melanoma development remains unclear, particularly in postmenopausal women who carry a lower melanoma risk. Objective: We examine the contribution of a combined polygenic risk score on melanoma development in postmenopausal women. Methods: Genetic risk scores were calculated using 21 genome-wide association study–significant SNPs. Their combined effect on melanoma development was evaluated in 19,102 postmenopausal white women in the clinical trial and observational study arms of the Women's Health Initiative dataset. Results: Compared to the tertile of weighted genetic risk score with the lowest genetic risk, the women in the tertile with the highest genetic risk were 1.9 times more likely to develop melanoma (95{\%} confidence interval 1.50-2.42). The incremental change in c-index from adding genetic risk scores to age were 0.075 (95{\%} confidence interval 0.041-0.109) for incident melanoma. Limitations: Limitations include a lack of information on nevi count, Fitzpatrick skin type, family history of melanoma, and potential reporting and selection bias in the Women's Health Initiative cohort. Conclusion: Higher genetic risk is associated with increased melanoma prevalence and incidence in postmenopausal women, but current genetic information may have a limited role in risk prediction when phenotypic information is available.",
keywords = "genetic risk score, melanoma, postmenopausal, single-nucleotide polymorphism, women, Women's Health Initiative",
author = "Cho, {Hyunje G.} and Ransohoff, {Katherine J.} and Lingyao Yang and Haley Hedlin and Themistocles Assimes and Jiali Han and Marcia Stefanick and Tang, {Jean Y.} and Sarin, {Kavita Y.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.jaad.2018.02.052",
language = "English (US)",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",

}

TY - JOUR

T1 - Melanoma risk prediction using a multilocus genetic risk score in the Women's Health Initiative cohort

AU - Cho, Hyunje G.

AU - Ransohoff, Katherine J.

AU - Yang, Lingyao

AU - Hedlin, Haley

AU - Assimes, Themistocles

AU - Han, Jiali

AU - Stefanick, Marcia

AU - Tang, Jean Y.

AU - Sarin, Kavita Y.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Background: Single-nucleotide polymorphisms (SNPs) associated with melanoma have been identified though genome-wide association studies. However, the combined impact of these SNPs on melanoma development remains unclear, particularly in postmenopausal women who carry a lower melanoma risk. Objective: We examine the contribution of a combined polygenic risk score on melanoma development in postmenopausal women. Methods: Genetic risk scores were calculated using 21 genome-wide association study–significant SNPs. Their combined effect on melanoma development was evaluated in 19,102 postmenopausal white women in the clinical trial and observational study arms of the Women's Health Initiative dataset. Results: Compared to the tertile of weighted genetic risk score with the lowest genetic risk, the women in the tertile with the highest genetic risk were 1.9 times more likely to develop melanoma (95% confidence interval 1.50-2.42). The incremental change in c-index from adding genetic risk scores to age were 0.075 (95% confidence interval 0.041-0.109) for incident melanoma. Limitations: Limitations include a lack of information on nevi count, Fitzpatrick skin type, family history of melanoma, and potential reporting and selection bias in the Women's Health Initiative cohort. Conclusion: Higher genetic risk is associated with increased melanoma prevalence and incidence in postmenopausal women, but current genetic information may have a limited role in risk prediction when phenotypic information is available.

AB - Background: Single-nucleotide polymorphisms (SNPs) associated with melanoma have been identified though genome-wide association studies. However, the combined impact of these SNPs on melanoma development remains unclear, particularly in postmenopausal women who carry a lower melanoma risk. Objective: We examine the contribution of a combined polygenic risk score on melanoma development in postmenopausal women. Methods: Genetic risk scores were calculated using 21 genome-wide association study–significant SNPs. Their combined effect on melanoma development was evaluated in 19,102 postmenopausal white women in the clinical trial and observational study arms of the Women's Health Initiative dataset. Results: Compared to the tertile of weighted genetic risk score with the lowest genetic risk, the women in the tertile with the highest genetic risk were 1.9 times more likely to develop melanoma (95% confidence interval 1.50-2.42). The incremental change in c-index from adding genetic risk scores to age were 0.075 (95% confidence interval 0.041-0.109) for incident melanoma. Limitations: Limitations include a lack of information on nevi count, Fitzpatrick skin type, family history of melanoma, and potential reporting and selection bias in the Women's Health Initiative cohort. Conclusion: Higher genetic risk is associated with increased melanoma prevalence and incidence in postmenopausal women, but current genetic information may have a limited role in risk prediction when phenotypic information is available.

KW - genetic risk score

KW - melanoma

KW - postmenopausal

KW - single-nucleotide polymorphism

KW - women

KW - Women's Health Initiative

UR - http://www.scopus.com/inward/record.url?scp=85045021990&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045021990&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2018.02.052

DO - 10.1016/j.jaad.2018.02.052

M3 - Article

C2 - 29499294

AN - SCOPUS:85045021990

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

ER -